Risk factors for negative impacts on sexual activity and function in younger breast cancer survivors

被引:43
作者
Lee, Maria [1 ]
Kim, Yun Hwan [2 ]
Jeon, Myung Jae [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 110799, South Korea
[2] Ewha Womans Univ, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea
关键词
QUALITY-OF-LIFE; WOMEN; DISTRESS; DYSFUNCTION; THERAPY; MASTECTOMY; TIME; AGE;
D O I
10.1002/pon.3772
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective We aim to examine changes in sexual activity and function among younger breast cancer survivors who were sexually active before diagnosis and to investigate risk factors for negative impacts on them. Methods An observational cohort study enrolled 304 premenopausal and sexually active women diagnosed with early stage breast cancer. Questionnaires were completed, and sexual activity was measured at two time points: after surgery, to assess sexual activity and function before diagnosis, and then at least 12months after the completion of chemotherapy or endocrine therapy. For each domain of the Female Sexual Function Index, a score below 3 was classified as indicative of a sexual problem. Each sexual problem was considered to be dysfunctional if it was associated with distress. Results The median age at the last survey was 46.0years (range: 23-57). Of the participants, 35 (11.5%) became sexually inactive after treatment. Among the 269 women who remained sexually active, 31.6% were currently experiencing sexual dysfunction, which was significantly higher compared with the frequency before diagnosis. In the multivariate logistic regression model, chemo-related menopause, thyroid dysfunction, and depression were independent risk factors for sexual inactivity. Chemo-related menopause was a significant risk factor for sexual dysfunction. Conclusions Chemo-related menopause was significantly associated with both sexual inactivity and dysfunction after treatment. Thyroid dysfunction and depression were risk factors for sexual inactivity in younger breast cancer survivors. Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:1097 / 1103
页数:7
相关论文
共 41 条
  • [1] Sexual dysfunction after premenopausal Stage I and II breast cancer: Do androgens play a role?
    Alder, Judith
    Zanetti, Rosanna
    Wight, Edward
    Urech, Corinne
    Fink, Nadine
    Bitzer, Johannes
    [J]. JOURNAL OF SEXUAL MEDICINE, 2008, 5 (08) : 1898 - 1906
  • [2] Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study
    Arndt, Volker
    Stegmaier, Christa
    Ziegler, Hartwig
    Brenner, Hermann
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (12) : 1311 - 1318
  • [3] Arora NK, 2001, CANCER, V92, P1288, DOI 10.1002/1097-0142(20010901)92:5<1288::AID-CNCR1450>3.0.CO
  • [4] 2-E
  • [5] Female sexual dysfunction
    Aslan, Erdogan
    Fynes, Michelle
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 (02) : 293 - 305
  • [6] Psychosocial problems among younger women with breast cancer
    Avis, NE
    Crawford, S
    Manuel, J
    [J]. PSYCHO-ONCOLOGY, 2004, 13 (05) : 295 - 308
  • [7] Development of a Korean version of the Female Sexual Distress Scale
    Bae, Jae Hyun
    Han, Chang Su
    Kang, Seok Ho
    Shim, Kang Soo
    Kim, Je Jong
    Moon, Du Geon
    [J]. JOURNAL OF SEXUAL MEDICINE, 2006, 3 (06) : 1013 - 1017
  • [8] Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760
  • [9] Effect of endocrine treatment on sexuality in premenopausal breast cancer patients:: A prospective randomized study
    Berglund, G
    Nystedt, M
    Bolund, C
    Sjödén, PO
    Rutquist, LE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2788 - 2796
  • [10] Effect of screening and adjuvant therapy on mortality from breast cancer
    Berry, DA
    Cronin, KA
    Plevritis, SK
    Fryback, DG
    Clarke, L
    Zelen, M
    Mandelblatt, JS
    Yakovlev, AY
    Habbema, JDF
    Feuer, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) : 1784 - 1792